Guangzhou Four-Leaf Clover HealthTech Co., Ltd. Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2019
NCT03975101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Guangzhou Four-Leaf Clover HealthTech Co., Ltd.